+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Lennox-Gastaut Syndrome Treatment Market 2024-2028

  • PDF Icon

    Report

  • 161 Pages
  • January 2024
  • Region: Global
  • TechNavio
  • ID: 5661056
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The lennox-gastaut syndrome treatment market is forecasted to grow by USD 699.8 mn during 2023-2028, accelerating at a CAGR of 4.29% during the forecast period. The report on the lennox-gastaut syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in medical research on LGS, growing awareness of LGS, and increasing prevalence of LGS.

The lennox-gastaut syndrome treatment market is segmented as below:

By Type

  • Non-surgical treatment
  • Surgical treatment

By End-user

  • Hospitals
  • Specialty clinics
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rise of minimally invasive procedures for LGS as one of the prime reasons driving the lennox-gastaut syndrome treatment market growth during the next few years. Also, advancements in precision medicine for LGS and growing adoption of telehealth and telemedicine services for LGS will lead to sizable demand in the market.

The report on the lennox-gastaut syndrome treatment market covers the following areas:

  • Lennox-gastaut syndrome treatment market sizing
  • Lennox-gastaut syndrome treatment market forecast
  • Lennox-gastaut syndrome treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lennox-gastaut syndrome treatment market vendors that include Akron Childrens Hospital, Amneal Pharmaceuticals Inc., Aquestive Therapeutics Inc., Bausch Health Companies Inc., Cedars Sinai Health System, Cision US Inc., Eisai Co. Ltd., Epilepsy Foundation, GlaxoSmithKline Plc, H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson, Lupin Ltd., Marinus Pharmaceuticals Inc., Sawai Group Holdings Co. Ltd., Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc.. Also, the lennox-gastaut syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global lennox-gastaut syndrome treatment market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global lennox-gastaut syndrome treatment market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Non-surgical treatment - Market size and forecast 2023-2028
Exhibit 34: Chart on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
6.4 Surgical treatment - Market size and forecast 2023-2028
Exhibit 38: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Specialty clinics - Market size and forecast 2023-2028
Exhibit 52: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Akron Childrens Hospital
Exhibit 111: Akron Childrens Hospital - Overview
Exhibit 112: Akron Childrens Hospital - Product/Service
Exhibit 113: Akron Childrens Hospital - Key offerings
12.4 Cedars Sinai Health System
Exhibit 114: Cedars Sinai Health System - Overview
Exhibit 115: Cedars Sinai Health System - Product/Service
Exhibit 116: Cedars Sinai Health System - Key offerings
12.5 Cision US Inc.
Exhibit 117: Cision US Inc. - Overview
Exhibit 118: Cision US Inc. - Product/Service
Exhibit 119: Cision US Inc. - Key offerings
12.6 Eisai Co. Ltd.
Exhibit 120: Eisai Co. Ltd. - Overview
Exhibit 121: Eisai Co. Ltd. - Business segments
Exhibit 122: Eisai Co. Ltd. - Key offerings
Exhibit 123: Eisai Co. Ltd. - Segment focus
12.7 Epilepsy Foundation
Exhibit 124: Epilepsy Foundation - Overview
Exhibit 125: Epilepsy Foundation - Product/Service
Exhibit 126: Epilepsy Foundation - Key offerings
12.8 GlaxoSmithKline Plc
Exhibit 127: GlaxoSmithKline Plc - Overview
Exhibit 128: GlaxoSmithKline Plc - Business segments
Exhibit 129: GlaxoSmithKline Plc - Key news
Exhibit 130: GlaxoSmithKline Plc - Key offerings
Exhibit 131: GlaxoSmithKline Plc - Segment focus
12.9 H Lundbeck AS
Exhibit 132: H Lundbeck AS - Overview
Exhibit 133: H Lundbeck AS - Product/Service
Exhibit 134: H Lundbeck AS - Key offerings
12.10 Johnson and Johnson
Exhibit 135: Johnson and Johnson - Overview
Exhibit 136: Johnson and Johnson - Business segments
Exhibit 137: Johnson and Johnson - Key news
Exhibit 138: Johnson and Johnson - Key offerings
Exhibit 139: Johnson and Johnson - Segment focus
12.11 Lupin Ltd.
Exhibit 140: Lupin Ltd. - Overview
Exhibit 141: Lupin Ltd. - Product/Service
Exhibit 142: Lupin Ltd. - Key news
Exhibit 143: Lupin Ltd. - Key offerings
12.12 Marinus Pharmaceuticals Inc.
Exhibit 144: Marinus Pharmaceuticals Inc. - Overview
Exhibit 145: Marinus Pharmaceuticals Inc. - Product/Service
Exhibit 146: Marinus Pharmaceuticals Inc. - Key offerings
12.13 Sawai Group Holdings Co. Ltd.
Exhibit 147: Sawai Group Holdings Co. Ltd. - Overview
Exhibit 148: Sawai Group Holdings Co. Ltd. - Product/Service
Exhibit 149: Sawai Group Holdings Co. Ltd. - Key offerings
12.14 Supernus Pharmaceuticals Inc.
Exhibit 150: Supernus Pharmaceuticals Inc. - Overview
Exhibit 151: Supernus Pharmaceuticals Inc. - Product/Service
Exhibit 152: Supernus Pharmaceuticals Inc. - Key offerings
12.15 Teva Pharmaceutical Industries Ltd.
Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 UCB SA
Exhibit 158: UCB SA - Overview
Exhibit 159: UCB SA - Product/Service
Exhibit 160: UCB SA - Key offerings
12.17 Viatris Inc.
Exhibit 161: Viatris Inc. - Overview
Exhibit 162: Viatris Inc. - Business segments
Exhibit 163: Viatris Inc. - Key news
Exhibit 164: Viatris Inc. - Key offerings
Exhibit 165: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 166: Inclusions checklist
Exhibit 167: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 168: Currency conversion rates for US$
13.4 Research methodology
Exhibit 169: Research methodology
Exhibit 170: Validation techniques employed for market sizing
Exhibit 171: Information sources
13.5 List of abbreviations
Exhibit 172: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global lennox-gastaut syndrome treatment market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Chart on End-user - Market share 2023-2028 (%)
Exhibits 45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by End-user
Exhibits 47: Data Table on Comparison by End-user
Exhibits 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by End-user ($ million)
Exhibits 61: Data Table on Market opportunity by End-user ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Akron Childrens Hospital - Overview
Exhibits 112: Akron Childrens Hospital - Product/Service
Exhibits 113: Akron Childrens Hospital - Key offerings
Exhibits 114: Cedars Sinai Health System - Overview
Exhibits 115: Cedars Sinai Health System - Product/Service
Exhibits 116: Cedars Sinai Health System - Key offerings
Exhibits 117: Cision US Inc. - Overview
Exhibits 118: Cision US Inc. - Product/Service
Exhibits 119: Cision US Inc. - Key offerings
Exhibits 120: Eisai Co. Ltd. - Overview
Exhibits 121: Eisai Co. Ltd. - Business segments
Exhibits 122: Eisai Co. Ltd. - Key offerings
Exhibits 123: Eisai Co. Ltd. - Segment focus
Exhibits 124: Epilepsy Foundation - Overview
Exhibits 125: Epilepsy Foundation - Product/Service
Exhibits 126: Epilepsy Foundation - Key offerings
Exhibits 127: GlaxoSmithKline Plc - Overview
Exhibits 128: GlaxoSmithKline Plc - Business segments
Exhibits 129: GlaxoSmithKline Plc - Key news
Exhibits 130: GlaxoSmithKline Plc - Key offerings
Exhibits 131: GlaxoSmithKline Plc - Segment focus
Exhibits 132: H Lundbeck AS - Overview
Exhibits 133: H Lundbeck AS - Product/Service
Exhibits 134: H Lundbeck AS - Key offerings
Exhibits 135: Johnson and Johnson - Overview
Exhibits 136: Johnson and Johnson - Business segments
Exhibits 137: Johnson and Johnson - Key news
Exhibits 138: Johnson and Johnson - Key offerings
Exhibits 139: Johnson and Johnson - Segment focus
Exhibits 140: Lupin Ltd. - Overview
Exhibits 141: Lupin Ltd. - Product/Service
Exhibits 142: Lupin Ltd. - Key news
Exhibits 143: Lupin Ltd. - Key offerings
Exhibits 144: Marinus Pharmaceuticals Inc. - Overview
Exhibits 145: Marinus Pharmaceuticals Inc. - Product/Service
Exhibits 146: Marinus Pharmaceuticals Inc. - Key offerings
Exhibits 147: Sawai Group Holdings Co. Ltd. - Overview
Exhibits 148: Sawai Group Holdings Co. Ltd. - Product/Service
Exhibits 149: Sawai Group Holdings Co. Ltd. - Key offerings
Exhibits 150: Supernus Pharmaceuticals Inc. - Overview
Exhibits 151: Supernus Pharmaceuticals Inc. - Product/Service
Exhibits 152: Supernus Pharmaceuticals Inc. - Key offerings
Exhibits 153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 157: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 158: UCB SA - Overview
Exhibits 159: UCB SA - Product/Service
Exhibits 160: UCB SA - Key offerings
Exhibits 161: Viatris Inc. - Overview
Exhibits 162: Viatris Inc. - Business segments
Exhibits 163: Viatris Inc. - Key news
Exhibits 164: Viatris Inc. - Key offerings
Exhibits 165: Viatris Inc. - Segment focus
Exhibits 166: Inclusions checklist
Exhibits 167: Exclusions checklist
Exhibits 168: Currency conversion rates for US$
Exhibits 169: Research methodology
Exhibits 170: Validation techniques employed for market sizing
Exhibits 171: Information sources
Exhibits 172: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global lennox-gastaut syndrome treatment market: Akron Childrens Hospital, Amneal Pharmaceuticals Inc., Aquestive Therapeutics Inc., Bausch Health Companies Inc., Cedars Sinai Health System, Cision US Inc., Eisai Co. Ltd., Epilepsy Foundation, GlaxoSmithKline Plc, H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson, Lupin Ltd., Marinus Pharmaceuticals Inc., Sawai Group Holdings Co. Ltd., Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rise of minimally invasive procedures for LGS.'

According to the report, one of the major drivers for this market is the advancements in medical research on LGS.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Akron Childrens Hospital
  • Amneal Pharmaceuticals Inc.
  • Aquestive Therapeutics Inc.
  • Bausch Health Companies Inc.
  • Cedars Sinai Health System
  • Cision US Inc.
  • Eisai Co. Ltd.
  • Epilepsy Foundation
  • GlaxoSmithKline Plc
  • H Lundbeck AS
  • Jazz Pharmaceuticals Plc
  • Johnson and Johnson
  • Lupin Ltd.
  • Marinus Pharmaceuticals Inc.
  • Sawai Group Holdings Co. Ltd.
  • Supernus Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • UCB SA
  • Viatris Inc.

Related Topics

Related Reports

Global Lennox-Gastaut Syndrome Treatment Market by Therapy Type (Non-Surgical Treatment, Surgery), Route of Administration (Oral, Parenteral), Distribution Channel, End Users - Forecast 2024-2030 - Product Image

Global Lennox-Gastaut Syndrome Treatment Market by Therapy Type (Non-Surgical Treatment, Surgery), Route of Administration (Oral, Parenteral), Distribution Channel, End Users - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Lennox-Gastaut Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Image

Lennox-Gastaut Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • 169 Pages
  • Global
From
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 - Product Image

Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024

  • Clinical Trials
  • 176 Pages
  • Global
From
Lennox Gastaut Syndrome - Pipeline Insight, 2024 - Product Image

Lennox Gastaut Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Global Tardive Dyskinesia Treatment Market 2024-2028 - Product Image

Global Tardive Dyskinesia Treatment Market 2024-2028

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.